Details of the Drug

General Information of Drug (ID: DMM8TE0)

Drug Name
(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline
Synonyms N-Benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline; N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline; CHEMBL570775; SCHEMBL4314176; HITMFLNAOQIZSN-QGZVFWFLSA-N; BDBM50294163; DB07260
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 282.4
Logarithm of the Partition Coefficient (xlogp) 3.5
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C18H22N2O
IUPAC Name
N-benzyl-4-[[(2R)-pyrrolidin-2-yl]methoxy]aniline
Canonical SMILES
C1C[C@@H](NC1)COC2=CC=C(C=C2)NCC3=CC=CC=C3
InChI
InChI=1S/C18H22N2O/c1-2-5-15(6-3-1)13-20-16-8-10-18(11-9-16)21-14-17-7-4-12-19-17/h1-3,5-6,8-11,17,19-20H,4,7,12-14H2/t17-/m1/s1
InChIKey
HITMFLNAOQIZSN-QGZVFWFLSA-N
Cross-matching ID
PubChem CID
44129620
DrugBank ID
DB07260
TTD ID
D01RVF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukotriene A-4 hydrolase (LTA4H) TTXZEAJ LKHA4_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Leukotriene A-4 hydrolase (LTA4H) DTT LTA4H 1.31E-48 -1.22 -2.21
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.